Cargando…
Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
OBJECTIVES: T cells play an essential role in controlling the development of B‐cell lymphoproliferative disorders (BLPDs), but the dysfunction of T cells in BLPDs largely remains elusive. METHODS: Using multiplexed flow cytometry, we quantified all major subsets of CD4(+) helper T cells (Th) and CD8...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975127/ https://www.ncbi.nlm.nih.gov/pubmed/31993200 http://dx.doi.org/10.1002/cti2.1105 |
_version_ | 1783490235839021056 |
---|---|
author | Yi, Shuhua Zhang, Yu Xiong, Wenjie Chen, Weiwei Hou, Zhaohua Yang, Yang Yan, Yuting Wei, Yunbo Cui, Rui Wang, Huijun Yu, Zhen Li, Heng Li, Zengjun Liu, Wei Lv, Rui Wang, Tingyu Ru, Kun Zou, Dehui Shu, Minglei Qiu, Lugui Yu, Di |
author_facet | Yi, Shuhua Zhang, Yu Xiong, Wenjie Chen, Weiwei Hou, Zhaohua Yang, Yang Yan, Yuting Wei, Yunbo Cui, Rui Wang, Huijun Yu, Zhen Li, Heng Li, Zengjun Liu, Wei Lv, Rui Wang, Tingyu Ru, Kun Zou, Dehui Shu, Minglei Qiu, Lugui Yu, Di |
author_sort | Yi, Shuhua |
collection | PubMed |
description | OBJECTIVES: T cells play an essential role in controlling the development of B‐cell lymphoproliferative disorders (BLPDs), but the dysfunction of T cells in BLPDs largely remains elusive. METHODS: Using multiplexed flow cytometry, we quantified all major subsets of CD4(+) helper T cells (Th) and CD8(+) cytotoxic T cells (Tc) in 94 BLPD patients and 66 healthy controls. Statistics was utilised to rank T‐cell signatures that distinguished BLPDs from healthy controls and differentially presented between indolent and aggressive categories. RESULTS: By comparing with healthy controls, we found that the indolent but not aggressive type of BLPDs demonstrated a high degree of T‐cell activation, showing the increase in type I helper T (Th1) cells and follicular B‐helper T (Tfh) cells, both of which strongly associated with the enhanced differentiation of exhaustion‐like effector cytotoxic CD8(+) T cells expressing PD‐1 (Tc exhaustion‐like) in indolent BLPDs. Random forest modelling selected a module of T‐cell immune signatures best performing binary classification of all BLPD patients. This signature module was composed of low naïve Th cells and high Th1, Tfh and Tc exhaustion‐like cells which efficiently identified > 85% indolent cases and was, therefore, assigned as the Indolent Dominant Module of T‐cell immune signature. In indolent BLPD patients, a strong bias towards such signatures was found to associate with clinical characteristics of worse prognosis. CONCLUSION: Our study identified a prominent signature of T‐cell dysregulation specifically for indolent BLPDs, suggesting Th1, Tfh and Tc exhaustion‐like cells represent potential prognostic biomarkers and targets for immunotherapies. |
format | Online Article Text |
id | pubmed-6975127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69751272020-01-28 Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis Yi, Shuhua Zhang, Yu Xiong, Wenjie Chen, Weiwei Hou, Zhaohua Yang, Yang Yan, Yuting Wei, Yunbo Cui, Rui Wang, Huijun Yu, Zhen Li, Heng Li, Zengjun Liu, Wei Lv, Rui Wang, Tingyu Ru, Kun Zou, Dehui Shu, Minglei Qiu, Lugui Yu, Di Clin Transl Immunology Short Communication OBJECTIVES: T cells play an essential role in controlling the development of B‐cell lymphoproliferative disorders (BLPDs), but the dysfunction of T cells in BLPDs largely remains elusive. METHODS: Using multiplexed flow cytometry, we quantified all major subsets of CD4(+) helper T cells (Th) and CD8(+) cytotoxic T cells (Tc) in 94 BLPD patients and 66 healthy controls. Statistics was utilised to rank T‐cell signatures that distinguished BLPDs from healthy controls and differentially presented between indolent and aggressive categories. RESULTS: By comparing with healthy controls, we found that the indolent but not aggressive type of BLPDs demonstrated a high degree of T‐cell activation, showing the increase in type I helper T (Th1) cells and follicular B‐helper T (Tfh) cells, both of which strongly associated with the enhanced differentiation of exhaustion‐like effector cytotoxic CD8(+) T cells expressing PD‐1 (Tc exhaustion‐like) in indolent BLPDs. Random forest modelling selected a module of T‐cell immune signatures best performing binary classification of all BLPD patients. This signature module was composed of low naïve Th cells and high Th1, Tfh and Tc exhaustion‐like cells which efficiently identified > 85% indolent cases and was, therefore, assigned as the Indolent Dominant Module of T‐cell immune signature. In indolent BLPD patients, a strong bias towards such signatures was found to associate with clinical characteristics of worse prognosis. CONCLUSION: Our study identified a prominent signature of T‐cell dysregulation specifically for indolent BLPDs, suggesting Th1, Tfh and Tc exhaustion‐like cells represent potential prognostic biomarkers and targets for immunotherapies. John Wiley and Sons Inc. 2020-01-22 /pmc/articles/PMC6975127/ /pubmed/31993200 http://dx.doi.org/10.1002/cti2.1105 Text en © 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Yi, Shuhua Zhang, Yu Xiong, Wenjie Chen, Weiwei Hou, Zhaohua Yang, Yang Yan, Yuting Wei, Yunbo Cui, Rui Wang, Huijun Yu, Zhen Li, Heng Li, Zengjun Liu, Wei Lv, Rui Wang, Tingyu Ru, Kun Zou, Dehui Shu, Minglei Qiu, Lugui Yu, Di Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis |
title | Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis |
title_full | Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis |
title_fullStr | Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis |
title_full_unstemmed | Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis |
title_short | Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis |
title_sort | prominent immune signatures of t cells are specifically associated with indolent b‐cell lymphoproliferative disorders and predict prognosis |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975127/ https://www.ncbi.nlm.nih.gov/pubmed/31993200 http://dx.doi.org/10.1002/cti2.1105 |
work_keys_str_mv | AT yishuhua prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT zhangyu prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT xiongwenjie prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT chenweiwei prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT houzhaohua prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT yangyang prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT yanyuting prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT weiyunbo prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT cuirui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT wanghuijun prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT yuzhen prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT liheng prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT lizengjun prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT liuwei prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT lvrui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT wangtingyu prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT rukun prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT zoudehui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT shuminglei prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT qiulugui prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis AT yudi prominentimmunesignaturesoftcellsarespecificallyassociatedwithindolentbcelllymphoproliferativedisordersandpredictprognosis |